NCT01759979

Brief Summary

Very large bile duct stones are difficult to remove. The prefered method involves an endoscopic procedure known as endoscopic retrograde cholangiopancreatography (ERCP)performed using a special side viewing endoscope. In the past small baskets passed through the scope into the bile duct have been used to remove most stones using mechanical force. Recently very small scopes known as cholangioscope have been introduced through the side viewing endoscope directly into the bile duct. These cholangioscopes may be used to guide laser therapy of bile duct stones. The investigators suspect that stone destruction using cholangioscopy guided laser stone destruction may enable bile duct stones to be removed more quickly and safely when added to the mechanical techniques.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 31, 2012

Completed
1 day until next milestone

Study Start

First participant enrolled

January 1, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 3, 2013

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
Last Updated

March 31, 2017

Status Verified

March 1, 2017

Enrollment Period

3.2 years

First QC Date

December 31, 2012

Last Update Submit

March 30, 2017

Conditions

Keywords

Cholelithiasis, Common Bile DuctCholedocholithiasis

Outcome Measures

Primary Outcomes (1)

  • Bile Duct Stone Clearance

    Confirmation that no further stones remain in the bile duct of the patient by cholangiography. Additionally, serum laboratory abnormalities in AST, ALT, Alkaline Phophatase, or bilirubin, or epigastric abdominal pain attributable to bile duct stones.

    12 months

Secondary Outcomes (6)

  • Number of ERCP

    12 months

  • Total Procedure Time

    12 months

  • Estimated Procedure Cost

    12 months

  • Cholangitis

    12 months

  • Pancreatitis

    12 months

  • +1 more secondary outcomes

Study Arms (2)

Laser and mechanical lithotripsy

EXPERIMENTAL

Bile duct stones with be treated with cholangioscopy guided laser therapy in addition to mechanical basket and balloon techniques.

Procedure: Laser and mechanical lithotripsy

Mechanical lithotripsy

ACTIVE COMPARATOR

Patients in the mechanical lithotripsy arm will undergo treatment only with basket and balloon for removal of large stones.

Procedure: Mechanical Lithotripsy

Interventions

Patients will undergo cholangioscopy guided laser treatment in addition to treatment with mechanical lithotripsy using basket and balloon techniques.

Also known as: Spyglass cholangioscopy, Holmium laser lithotripsy
Laser and mechanical lithotripsy

Patients in the mechanical lithotripsy arm will undergo treatment only with basket and balloons to facilitate stone removal but not laser lithotripsy.

Mechanical lithotripsy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Bile duct stone \>1cm demonstrated on ultrasound, computed tomography, or magnetic resonance imaging
  • Bile duct dilatation \>1cm

You may not qualify if:

  • Biliary, gallbladder or pancreatic malignancy
  • Pregnant
  • Prior biliary diversion surgery
  • Under age 18
  • Unable to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Los Angeles County Hospital

Los Angeles, California, 90033, United States

Location

Related Publications (5)

  • Lee JG. Diagnosis and management of acute cholangitis. Nat Rev Gastroenterol Hepatol. 2009 Sep;6(9):533-41. doi: 10.1038/nrgastro.2009.126. Epub 2009 Aug 4.

    PMID: 19652653BACKGROUND
  • Moon JH, Ko BM, Choi HJ, Hong SJ, Cheon YK, Cho YD, Lee JS, Lee MS, Shim CS. Intraductal balloon-guided direct peroral cholangioscopy with an ultraslim upper endoscope (with videos). Gastrointest Endosc. 2009 Aug;70(2):297-302. doi: 10.1016/j.gie.2008.11.019. Epub 2009 Apr 25.

    PMID: 19394010BACKGROUND
  • Kim HI, Moon JH, Choi HJ, Lee JC, Ahn HS, Song AR, Lee TH, Cho YD, Park SH, Kim SJ. Holmium laser lithotripsy under direct peroral cholangioscopy by using an ultra-slim upper endoscope for patients with retained bile duct stones (with video). Gastrointest Endosc. 2011 Nov;74(5):1127-32. doi: 10.1016/j.gie.2011.07.027. Epub 2011 Sep 29.

    PMID: 21963070BACKGROUND
  • Chen YK, Parsi MA, Binmoeller KF, Hawes RH, Pleskow DK, Slivka A, Haluszka O, Petersen BT, Sherman S, Deviere J, Meisner S, Stevens PD, Costamagna G, Ponchon T, Peetermans JA, Neuhaus H. Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos). Gastrointest Endosc. 2011 Oct;74(4):805-14. doi: 10.1016/j.gie.2011.04.016. Epub 2011 Jul 18.

    PMID: 21762903BACKGROUND
  • Langman MJ, Constantinopoulos A, Bouchier IA. ABO blood groups, secretor status, and intestinal mucosal concentrations of alkaline phosphatase. Nature. 1968 Mar 2;217(5131):863-5. doi: 10.1038/217863a0. No abstract available.

    PMID: 5641153BACKGROUND

MeSH Terms

Conditions

Choledocholithiasis

Interventions

Lasers

Condition Hierarchy (Ancestors)

Common Bile Duct DiseasesBile Duct DiseasesBiliary Tract DiseasesDigestive System DiseasesCholelithiasis

Intervention Hierarchy (Ancestors)

Optical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Study Officials

  • James L Buxbaum, MD

    University of Southern California

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Endoscopy, Los Angeles County Hospital

Study Record Dates

First Submitted

December 31, 2012

First Posted

January 3, 2013

Study Start

January 1, 2013

Primary Completion

March 1, 2016

Study Completion

March 1, 2016

Last Updated

March 31, 2017

Record last verified: 2017-03

Locations